NOTCH1 and Miyoshi myopathy: Silencing Notch receptor 1 or blocking integrin αvβ5 with an antibody reduced MM cell adhesion to vitronectin and reverted in MM cells the protection from doxorubicin pro-apoptotic effects conferred by adhesion to vitronectin[72].